XOMA
Turnstone Biologics Corp - Deal Valued at $0.34 per Share Plus CVR
时间:2025-06-27 19:30:00 市场: 美股 综合
Turnstone Biologics Corp. Enters Into Agreement to Be Acquired by XOMA Royalty Corporation for $0.34 in Cash per Share Plus a Contingent Value Right
时间:2025-06-27 19:30:00 市场: 美股 综合
XOMA Royalty Corp : Leerink Partners Raises Target Price to $55 From $49
时间:2024-11-08 19:09:36 市场: 美股 综合
XOMA Royalty: on Oct 21 XOMA Entered Royalty Purchase Agreement With Twist Bioscience
时间:2024-10-22 20:18:43 市场: 美股 综合
Zevra’s Miplyffa™ (Arimoclomol) Receives Approval From U.S. Food and Drug Administration for Use in Patients With Niemann-Pick Disease Type C (Npc)
时间:2024-09-23 18:30:00 市场: 美股 综合